Genomic Revolution Multi-Sector ETF Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 23 Posts
1 2
A Deep Dive Into ARK ETFs
Video By: Neena Mishra Wednesday, January 20, 2021 9:47 PM EST
ARK has been one of the biggest stories in the ETF world lately. With an incredible asset growth of more than 1000%, ARK is now a top 10 ETF issuer.
In this video: ARKW, ARKK, ARKG Also: TSLA, GBTC, SQ, CRSP, ROKU, TWST
Watch
5 Sector ETFs That Beat The Market In 2020
Article By: Sweta Killa Monday, December 28, 2020 3:00 PM EST
While there have been winners in many corners of the space, here are five sector ETFs that have been outperforming this year.
In this article: TAN, ARKK, IBUY, ARKG, WCLD Also: PFE, MRNA, BNTX
Read
4 Best ETF Sectors Of Q4
Article By: Zacks Investment Research Sunday, December 27, 2020 2:21 AM EST
Small caps beat the major indexes, but the sectors that did even better are clean energy, regional banking, cannabis, and biotech.
In this article: KBWR, GNOM, QCLN, KRE, TAN, ARKG, YOLO, CNBS, MSOS Also: QQQ, DIA, IWM, SPY
Read
Longevity Stocks
Article By: Fred Fuld Monday, December 14, 2020 4:13 AM EST
There are several companies working on helping you achieve a greater longevity, which are involved in targeting human aging and degenerative diseases. Here are several that are close to longevity pure plays.
In this article: ACET, LNGR, ARKG, UBX, CWBR, AGE, LCTX Also: MSFT, PYPL
Read
ETFs In Focus On Bayer's Bet On Gene Therapy
Article By: Sweta Killa Thursday, October 29, 2020 11:58 PM EST
Merger and acquisition activities have heated up in recent months and the niche spaces are in the limelight. After the telemedicine industry, gene therapy stocks jumped on the bandwagon.
In this article: GNOM, PBE, ARKG, IDNA
Read
4 Sector ETFs That Have Doubled This Year
Article By: Sweta Killa Friday, October 23, 2020 5:20 PM EST
While there have been winners in many corners of the space, we highlight four sector ETFs that have doubled so far this year:
In this article: XVZ, TAN, ARKW, ARKG
Read
FV Why You Should Invest In Genomics ETFs
Video By: Neena Mishra Thursday, October 15, 2020 1:09 PM EST
Biotech ETFs have done quite well this year as many pharma and biotech companies are working on coronavirus vaccines, therapeutics, and testing.
In this video: GNOM, ARKG, IDNA Also: REGN, GILD, NVTA, CRSP
Watch
Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak
Article By: Zacks Investment Research Tuesday, July 14, 2020 2:00 AM EST
The coronavirus outbreak seems to get severe in the United States as more than 3.3 million cases have been recorded with a death toll of at least 135,205.
In this article: BIB, XBI, ARKG, IDNA
Read
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
Article By: Zacks Investment Research Sunday, July 5, 2020 1:58 PM EST
The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to the biotech sector:
In this article: IBB, BBH, FBT, XBI, ARKG Also: AZN, JNJ, PFE, MRNA
Read
Race For Coronavirus Vaccine Heats Up: Biotech ETFs To Gain
Article By: Sweta Killa Wednesday, May 27, 2020 11:34 AM EST
Given rising spending on drugs and healthcare all over the world, investors should tap the opportune moment by investing in the biotech sector.
In this article: GNOM, IBB, BBH, XBI, BBC, ARKG Also: GSK, MRK, PFE, MRNA
Read
3 Genomics ETFs Worth Jumping For
Article By: Benzinga Tuesday, May 26, 2020 8:01 PM EST
The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, more nuanced exchange-traded funds targeting the group are delivering impressive returns.
In this article: HELX, GNOM, ARKG Also: MRNA
Read
Profit From The Genomics Market Momentum With These ETFs
Article By: Zacks Investment Research Saturday, May 23, 2020 7:04 PM EST
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that investors can keep tabs on.
In this article: GSK, GNOM, PBE, ARKG, IDNA
Read
EC Healthcare, Meet Momentum
Article By: Brad Zigler Wednesday, May 20, 2020 8:12 PM EST
The rush is on to develop vaccines and therapies.
In this article: ARKG, IDNA Also: INO, SPY, TWST
Read
Coronavirus Makes Biotech ETFs Red Hot
Article By: Sweta Killa Tuesday, April 21, 2020 10:40 PM EST
Biotech ETFs are surging with many hitting new 52-week highs lately.
In this article: IBB, BBH, FBT, ARKG, IEIH Also: PFE, REGN, AMGN, MRNA
Read
Why Biotech ETFs Are Surging To New Highs
Video By: Neena Mishra Tuesday, December 10, 2019 10:00 PM EST
We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive cancer treatment market.
In this video: XBI, BBC, SBIO, ARKG Also: MRK, NVS, SNY, ARQL, MDCO, THOR, GBT, AUPH, CRSP
Watch
5 U.S. ETFs Seeing Fireworks Ahead Of July Fourth
Article By: Sweta Killa Wednesday, July 3, 2019 2:40 PM EST
These funds focus exclusively on U.S. equities and deserve the attention of investors seeking a domestic tilt to their portfolio ahead of the Jul 4 holiday.
In this article: ARKG, PBW, PTF, IPO, DWAQ
Read
1 to 16 of 23 Posts
1 2